Best treatments for pancreatic neoplasms
14 products may treat pancreatic neoplasms, spanning FDA drug classes such as nucleoside metabolic inhibitor, somatostatin analog, microtubule inhibitor. The current highest-rated option is tolak. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 14 drugs we list for pancreatic neoplasms, 7 are available as lower-cost generics, spanning classes such as nucleoside metabolic inhibitor, somatostatin analog, microtubule inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for pancreatic neoplasms — so confirm the right choice with your prescriber.
Top-rated picks for pancreatic neoplasms: 1. Tolak · 2. Lutathera · 3. Sandostatin
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Topical | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 2 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 3 | 70/100 | Prescription | Injectable | Somatostatin Analog | Generic | $5 | View → | |
| 4 | 70/100 | Prescription | Injectable | Microtubule Inhibitor | No data | — | View → | |
| 5 | Not yet rated | Prescription | Injectable | Somatostatin Analog | Generic | $5 | View → | |
| 6 | Not yet rated | Prescription | Injectable | Microtubule Inhibitor | No data | — | View → | |
| 7 | Not yet rated | Prescription | Topical | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 8 | Not yet rated | Prescription | Injectable | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 9 | Not yet rated | Prescription | Topical | Nucleoside Metabolic Inhibitor | Generic | $1 | View → | |
| 10 | Not yet rated | Prescription | Injectable | Alkylating Drug | No data | — | View → |
Narrow by drug class
Explore the class hubs: nucleoside metabolic inhibitor · alkylating drug · somatostatin analog · microtubule inhibitor
Full ranking · 14 treatments
tolak
PrescriptionFDA-sourced
Tolak (Fluorouracil) is a nucleoside metabolic inhibitor used to treat Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms, Head and Neck Neoplasms.
Pharmacy pays
From ~$0.60· 4 formslutathera
PrescriptionFDA-sourced
Lutathera (Lutetium Lu 177 Dotatate) is a medication used to treat Gastrointestinal Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors.
Price varies
sandostatin
PrescriptionFDA-sourced
Sandostatin (Octreotide Acetate) is a somatostatin analog used to treat Acromegaly, Adenoma, Diarrhea, Pancreatic Neoplasms.
Pharmacy pays
$5.34 /mL
taxotere
Boxed warningPrescriptionFDA-sourced
Taxotere (Docetaxel) is a microtubule inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms, Melanoma.
Price varies
bynfezia pen
PrescriptionFDA-sourced
Bynfezia Pen (Octreotide Acetate) is a somatostatin analog used to treat Acromegaly, Adenoma, Diarrhea, Pancreatic Neoplasms.
Pharmacy pays
$5.34 /mL
docivyx
Boxed warningPrescriptionFDA-sourced
Docivyx (Docetaxel) is a microtubule inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Head and Neck Neoplasms, Melanoma.
Price varies
Frequently asked
- What treats pancreatic neoplasms?
- Our catalog lists 14 products that may treat pancreatic neoplasms, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is tolak.
- What is the best-rated treatment for pancreatic neoplasms?
- By our independent recall-safety rating — not an efficacy measure — tolak ranks highest among the products we list for pancreatic neoplasms. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat pancreatic neoplasms?
- Treatments for pancreatic neoplasms span FDA drug classes including nucleoside metabolic inhibitor, somatostatin analog, microtubule inhibitor, alkylating drug, kinase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.